Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Covetrus

Where Covetrus Stands With Analysts

Within the last quarter, Covetrus (NASDAQ:CVET) has observed the following analyst ratings:

Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022

Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of $5.92. Molecular Partners closed at $6.88 at the end of the last trading period.

CD&R, TPG Take Covetrus Private In $4B Deal

Clayton, Dubilier & Rice (CD&R), a private investment firm, and TPG Capital will acquire animal-health technology and services company Covetrus Inc (NASDAQ:CVET) for $21.00 per share, representing an enterprise value of approximately $4 billion. CD&R and its affiliates currently beneficially own approximately 24% of the company's outstanding shares of common stock. The transaction…

Raymond James View Skewed Scenarios On Absent Supportive Bid For This Animal Health Stock

Raymond James downgraded the rating on Covetrus Inc (NASDAQ:CVET) from Outperform to Market Perform and removed the prior $22 price target after the company received a buyout at $21 per share. Though $21 may not ultimately prove to be the final resting place in terms of the offer price. Raymond James believes the proposed purchase…

Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022

inkl

Read news from The Economist, FT, and more,
with one subscription

Covetrus: Q4 Earnings Insights

Covetrus: Q4 Earnings Insights

Covetrus (NASDAQ:CVET) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Covetrus beat estimated earnings by 4.0%, reporting an EPS of $0.26 versus an estimate of $0.25.

Earnings Preview: Covetrus

Earnings Preview: Covetrus

Covetrus (NASDAQ:CVET) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement. Analysts estimate that Covetrus will report an earnings per share (EPS) of $0.25.

1

Organisations

Micron Technology

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

359,389 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play